Zhaoke Ophthalmology (6622.HK): Raising the 2023-24E adjusted net loss forecast; lowering the target price
浦銀國際Mar 28, 2023 00:00
Mega Ophthalmology (6622.HK): Cyclosporin A with controllable cash expenditure for the full year of 2021 will soon be put into production
浦銀國際Mar 25, 2022 00:00
Mega Ophthalmology-B (6622.HK) 1H21 performance: Cyclosporin A eye gel phase III reaches the main end point All clinical trials are progressing according to plan
浦銀國際Aug 19, 2021 00:00
Expected to see Zhaoke Ophthalmology (6622.HK): Overfall and rebound
浦銀國際Jul 27, 2021 00:00
Zhaoke Ophthalmology Clinic (6622.HK): New ophthalmologist sets sail
浦銀國際Jun 28, 2021 00:00
Zhaoke Ophthalmology-B (06622.HK): Ophthalmology products are widely distributed and market growth can be expected
興業證券Apr 23, 2021 00:00
IPO: Zhaoke Ophthalmology (06622.HK)
財通國際Apr 16, 2021 00:00
IPO News: Zhaoke Ophthalmology Co., Ltd. - B (6622.HK)
致富證券Apr 16, 2021 00:00
IPO Report: Zhaoke Ophthalmology-B (6622.HK)
中泰國際Apr 15, 2021 00:00
No Data
No Data